Denicourt C, Dowdy SF. Targeting apoptotic pathways in cancer cells.
Science. 2004 Sep 3;305(5689):1411-3.
pdf, journal
Wadia JS, Wagner MV, Ezhevsky SA, Dowdy SF. Apoptin/VP3 contains a concentration-dependent nuclear localization signal (NLS), not a tumorigenic selective NLS.
J. Virol. 2004 Jun;78(11):6077-8.
pdf, journal

Denicourt C, Dowdy SF. Cip/Kip proteins: more than just CDKs inhibitors.
Genes Dev. 2004 Apr 15;18(8):851-5.
pdf, journal

Snyder EL, Dowdy SF. Cell penetrating peptides in drug delivery.
Pharm Res. 2004 Mar;21(3):389-93.
pdf

Snyder EL, Meade BR, Saenz CC, Dowdy SF. Treatment of Terminal Peritoneal Carcinomatosis by a Transducible p53-Activating Peptide.
PLoS Biol. 2004 Feb;2(2):E36.
pdf, journal

Wadia JS, Stan RV, Dowdy SF. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis.
Nat Med. 2004 Mar;10(3):310-5.
pdf, journal

Denicourt C, Dowdy SF. Another twist in the transforming growth factor beta-induced cell-cycle arrest chronicle.
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15290-1.
pdf, journal

Yu BD, Becker-Hapak M, Snyder EL, Vooijs M, Denicourt C, Dowdy SF. Distinct and nonoverlapping roles for pRB and cyclin D:cyclin-dependent kinases 4/6 activity in melanocyte survival.
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14881-6.

Snyder EL, Meade BR, Dowdy SF. Anti-cancer protein transduction strategies: reconstitution of p27 tumor suppressor function.
J Control Release. 2003 Aug 28;91(1-2):45-51.

Denicourt C, Dowdy SF. Protein transduction technology offers novel therapeutic approach for brain ischemia.
Trends Pharmacol Sci. 2003 May;24(5):216-8.

Wadia JS, Dowdy SF. Modulation of cellular function by TAT mediated transduction of full length proteins.
Curr Protein Pept Sci. 2003 Apr;4(2):97-104.

McAllister SS, Becker-Hapak M, Pintucci G, Pagano M, Dowdy SF. Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions.
Mol Cell Biol. 2003 Jan;23(1):216-28.

Wadia JS, Dowdy SF. Protein transduction technology.
Curr Opin Biotechnol. 2002 Feb;13(1):52-6.

Ho A, Dowdy SF. Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes.
Curr Opin Genet Dev. 2002 Feb;12(1):47-52.

Davis PK, Dowdy SF. p73.
Int J Biochem Cell Biol. 2001 Oct;33(10):935-9.

Ezhevsky SA, Ho A, Becker-Hapak M, Davis PK, Dowdy SF. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo.
Mol Cell Biol. 2001 Jul;21(14):4773-84.

Davis PK, Ho A, Dowdy SF. Biological methods for cell-cycle synchronization of mammalian cells.
Biotechniques. 2001 Jun;30(6):1322-6, 1328, 1330-1.

Becker-Hapak M, McAllister SS, Dowdy SF. TAT-mediated protein transduction into mammalian cells.
Methods. 2001 Jul;24(3):247-56.

Snyder EL, Dowdy SF. Protein/peptide transduction domains: potential to deliver large DNA molecules into cells.
Curr Opin Mol Ther. 2001 Apr;3(2):147-52.

Vocero-Akbani A, Chellaiah MA, Hruska KA, Dowdy SF. Protein transduction: delivery of Tat-GTPase fusion proteins into mammalian cells.
Methods Enzymol. 2001;332:36-49.

Ho A, Schwarze SR, Mermelstein SJ, Waksman G, Dowdy SF. Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo.
Cancer Res. 2001 Jan 15;61(2):474-7.
Lissy NA, Davis PK, Irwin M, Kaelin WG, Dowdy SF. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation.
Nature. 2000 Oct 5;407(6804):642-5.
Vocero-Akbani A, Lissy NA, Dowdy SF. Transduction of full-length Tat fusion proteins directly into mammalian cells: analysis of T cell receptor activation-induced cell death.
Methods Enzymol. 2000;322:508-21.
Schwarze SR, Hruska KA, Dowdy SF. Protein transduction: unrestricted delivery into all cells?
Trends Cell Biol. 2000 Jul;10(7):290-5.
Schwarze SR, Dowdy SF. In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA.
Trends Pharmacol Sci. 2000 Feb;21(2):45-8.
Nagahara H, Ezhevsky SA, Vocero-Akbani AM, Kaldis P, Solomon MJ, Dowdy SF. Transforming growth factor beta targeted inactivation of cyclin E:cyclin-dependent kinase 2 (Cdk2) complexes by inhibition of Cdk2 activating kinase activity.
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14961-6.
Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF. In vivo protein transduction: delivery of a biologically active protein into the mouse.
Science. 1999 Sep 3;285(5433):1569-72.
Gius DR, Ezhevsky SA, Becker-Hapak M, Nagahara H, Wei MC, Dowdy SF. Transduced p16INK4a peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late G1.
Cancer Res. 1999 Jun 1;59(11):2577-80.
Nagahara H, Latek RR, Ezhevsky SA, Dowdy SF. 2-D phosphopeptide mapping.
Methods Mol Biol. 1999;112:271-9.
Vocero-Akbani AM, Heyden NV, Lissy NA, Ratner L, Dowdy SF. Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein.
Nat Med. 1999 Jan;5(1):29-33.
Nagahara H, Vocero-Akbani AM, Snyder EL, Ho A, Latham DG, Lissy NA, Becker-Hapak M, Ezhevsky SA, Dowdy SF. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration.
Nat Med. 1998 Dec;4(12):1449-52.
Lissy NA, Van Dyk LF, Becker-Hapak M, Vocero-Akbani A, Mendler JH, Dowdy SF. TCR antigen-induced cell death occurs from a late G1 phase cell cycle check point.
Immunity. 1998 Jan;8(1):57-65.
Ezhevsky SA, Nagahara H, Vocero-Akbani AM, Gius DR, Wei MC, Dowdy SF. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb.
Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10699-704.